Tag:
Rexin-G
Latest Headlines
Latest Headlines
Epeius' prostate cancer drug fast-tracked
Epeius Biotechnologies' lead product, Rexin-G, has been granted Fast Track designation by the FDA for use as a second-line treatment for advanced or metastatic pancreatic cancer. The drug is
